UroMems Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
67
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
13
UroMems General Information
Description
Developer of an implantable medical device designed to focus on designing, developing, and commercializing active implantable medical devices. The company's device improves current surgical treatments for as many patients as possible, particularly by reducing associated side effects, enabling patients to find the right treatment as soon as possible.
Contact Information
Website
www.uromems.comCorporate Office
- 5 Rue Raymond Chanas
- 38320 Eybens
- France
Corporate Office
- 5 Rue Raymond Chanas
- 38320 Eybens
- France
UroMems Timeline
UroMems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 6. Later Stage VC (Series C) | 21-May-2024 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jul-2023 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series B) | 06-Apr-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 15-Nov-2016 | $15.3M | $15.3M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
UroMems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
UroMems Comparisons
Industry
Financing
Details
UroMems Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Implantica | Corporation | Zug, Switzerland | ||||
| Medifocus | Corporate Backed or Acquired | Toronto, Canada | ||||
| Urologix | Formerly VC-backed | Minneapolis, MN | ||||
| iTind | Formerly VC-backed | Hadera, Israel | ||||
| Smart Medical Systems | Venture Capital-Backed | Ra'anana, Israel |
UroMems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
UroMems Patents
UroMems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3136364-A1 | Method for estimating a value representative of a fluid pressure in an inflatable element of an implantable medical device | Pending | 09-Jun-2022 | ||
| FR-3136365-A1 | Implantable medical device | Active | 09-Jun-2022 | ||
| FR-3136365-B1 | Implantable medical device | Active | 09-Jun-2022 | ||
| FR-3117373-B1 | Implantable medical device | Active | 10-Dec-2020 | ||
| FR-3117333-B1 | Implantable system comprising a variable volume reservoir | Active | 10-Dec-2020 | A61F2/004 |
UroMems Executive Team (6)
| Name | Title | Board Seat |
|---|---|---|
| Hamid Lamraoui Ph.D | Co-Founder, Chief Executive Officer, President, and Board Member | |
| Agnès Dimey | Chief Financial Officer | |
| Thomas Vial | Chief Operating Officer & Director of Operation | |
| Ash Keswani | Chief Marketing Officer | |
| Pierre Mozer MD | Co-Founder, Chief Medical Officer, Board Member and Clinical Director |
UroMems Board Members (15)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alain Ripart Ph.D | Self | Board Member | |
| Celia Hart Ph.D | Supernova Invest | Board Member | |
| Friedrich Hillebrand Ph.D | HIL-INVENT | Board Observer | |
| Hamid Lamraoui Ph.D | UroMems | Co-Founder, Chief Executive Officer, President, and Board Member | |
| Jerome Feraud | Self | Board Member |
UroMems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
UroMems Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Crédit Mutuel Innovation | Venture Capital | Minority | ||
| European Innovation Council Fund | Venture Capital | Minority | ||
| Horizon 2020 SME Instrument | Government | |||
| BlackRock | Asset Manager | Minority | ||
| Financiere Arbevel | PE-Backed Company | Minority |
UroMems FAQs
-
When was UroMems founded?
UroMems was founded in 2011.
-
Who is the founder of UroMems?
Hamid Lamraoui Ph.D, Pierre Mozer MD, and Stephane Lavallee Ph.D are the founders of UroMems.
-
Who is the CEO of UroMems?
Hamid Lamraoui Ph.D is the CEO of UroMems.
-
Where is UroMems headquartered?
UroMems is headquartered in Eybens, France.
-
What is the size of UroMems?
UroMems has 67 total employees.
-
What industry is UroMems in?
UroMems’s primary industry is Therapeutic Devices.
-
Is UroMems a private or public company?
UroMems is a Private company.
-
What is UroMems’s current revenue?
The current revenue for UroMems is .
-
How much funding has UroMems raised over time?
UroMems has raised $89.2M.
-
Who are UroMems’s investors?
Crédit Mutuel Innovation, European Innovation Council Fund, Horizon 2020 SME Instrument, BlackRock, and Financiere Arbevel are 5 of 13 investors who have invested in UroMems.
-
Who are UroMems’s competitors?
Implantica, Medifocus, Urologix, iTind, and Smart Medical Systems are some of the 12 competitors of UroMems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
